PT1102745E - PROCESS FOR THE PREPARATION OF CALCIUM SALT OF ZOFENOPRIL - Google Patents

PROCESS FOR THE PREPARATION OF CALCIUM SALT OF ZOFENOPRIL

Info

Publication number
PT1102745E
PT1102745E PT99939416T PT99939416T PT1102745E PT 1102745 E PT1102745 E PT 1102745E PT 99939416 T PT99939416 T PT 99939416T PT 99939416 T PT99939416 T PT 99939416T PT 1102745 E PT1102745 E PT 1102745E
Authority
PT
Portugal
Prior art keywords
zofenopril
salt
calcium salt
preparation
potassium salt
Prior art date
Application number
PT99939416T
Other languages
Portuguese (pt)
Inventor
Raffaello Giorgi
Antonio Giachetti
Carlo Mannucci
Anita Falezza
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of PT1102745E publication Critical patent/PT1102745E/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00Compounds of calcium, strontium, or barium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Abstract

A process for the preparation of polymorph A of zofenopril calcium salt in substantially pure form, which comprises: 1) reaction of S(-)-3-benzoylthio-2-methylpropanoic acid chloride with cis-4-phenylthio-L-proline in water at pH ranging from 9.0 to 9.5 and recovery of zofenopril in the acidic form; b) salification of acid zofenopril with a poyassium salt in alcoholic solution, and recovery of the resulting potassium salt; c) conversion of the potassium salt to the calcium salt by addition of zofenopril potassium salt aqueous solution to a CaCl2 aqueous solution at a temperature of 70-90° C. with simultaneous seeding to promote the precipitation of polymorph A.
PT99939416T 1998-08-04 1999-07-30 PROCESS FOR THE PREPARATION OF CALCIUM SALT OF ZOFENOPRIL PT1102745E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI001833A IT1301993B1 (en) 1998-08-04 1998-08-04 PROCESS FOR THE PREPARATION OF ZOFENOPRIL CALCIUM SALT.

Publications (1)

Publication Number Publication Date
PT1102745E true PT1102745E (en) 2004-08-31

Family

ID=11380611

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99939416T PT1102745E (en) 1998-08-04 1999-07-30 PROCESS FOR THE PREPARATION OF CALCIUM SALT OF ZOFENOPRIL

Country Status (32)

Country Link
US (2) US6521760B1 (en)
EP (1) EP1102745B1 (en)
JP (1) JP2002522417A (en)
KR (1) KR100593428B1 (en)
CN (1) CN1146538C (en)
AT (1) ATE266635T1 (en)
AU (1) AU5372299A (en)
BG (1) BG65022B1 (en)
BR (1) BR9912842A (en)
CA (1) CA2339283C (en)
CU (1) CU23171A3 (en)
CZ (1) CZ301908B6 (en)
DE (1) DE69917282T2 (en)
DK (1) DK1102745T3 (en)
EA (1) EA003454B1 (en)
EE (1) EE04798B1 (en)
ES (1) ES2221417T3 (en)
HK (1) HK1039616B (en)
HR (1) HRP20010083B1 (en)
HU (1) HU227557B1 (en)
IL (1) IL141222A0 (en)
IT (1) IT1301993B1 (en)
NO (1) NO319773B1 (en)
PL (1) PL193828B1 (en)
PT (1) PT1102745E (en)
RS (1) RS49768B (en)
SI (1) SI1102745T1 (en)
SK (1) SK285527B6 (en)
TR (1) TR200100272T2 (en)
UA (1) UA65628C2 (en)
WO (1) WO2000007984A1 (en)
ZA (1) ZA200100907B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2560502T3 (en) 2005-07-01 2016-02-19 Generics [Uk] Limited Zofenopril calcium in the form of polymorph C
EA012845B1 (en) * 2005-12-09 2009-12-30 Менарини Интернэшнл Оперейшнс Люксембург С. А. Pharmaceutical compositions comprising zofenopril and hctz for treating hypertension
DK2041083T3 (en) * 2006-05-26 2015-01-26 Generics Uk Ltd Methods for the preparation of zofenopril calcium
GB0715626D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Crystalline form of zofenopril calcium
WO2009106894A1 (en) * 2008-02-27 2009-09-03 Generics [Uk] Limited Novel crystalline forms
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
WO2010084515A2 (en) * 2009-01-23 2010-07-29 Glenmark Generics Limited A process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof
SI23949A (en) 2011-12-19 2013-06-28 Silverstone Pharma The new crystalline salts of zofenopril, the procedure for obtaining them and their use in therapy
CN104138359B (en) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 The preparation method of zofenopril calcium tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines

Also Published As

Publication number Publication date
CZ2001408A3 (en) 2001-07-11
ES2221417T3 (en) 2004-12-16
HRP20010083B1 (en) 2005-02-28
RS49768B (en) 2008-06-05
DK1102745T3 (en) 2004-08-02
JP2002522417A (en) 2002-07-23
WO2000007984A1 (en) 2000-02-17
BG105176A (en) 2001-11-30
AU5372299A (en) 2000-02-28
IL141222A0 (en) 2002-03-10
HK1039616A1 (en) 2002-05-03
EP1102745A1 (en) 2001-05-30
YU7501A (en) 2005-06-10
CN1146538C (en) 2004-04-21
SI1102745T1 (en) 2004-10-31
SK1632001A3 (en) 2001-09-11
EP1102745B1 (en) 2004-05-12
HRP20010083A2 (en) 2002-02-28
PL193828B1 (en) 2007-03-30
CZ301908B6 (en) 2010-07-28
NO319773B1 (en) 2005-09-12
ZA200100907B (en) 2001-10-04
EE04798B1 (en) 2007-04-16
EE200100065A (en) 2002-06-17
PL345814A1 (en) 2002-01-14
TR200100272T2 (en) 2001-05-21
KR100593428B1 (en) 2006-06-28
UA65628C2 (en) 2004-04-15
CN1316992A (en) 2001-10-10
ITMI981833A0 (en) 1998-08-04
NO20010552D0 (en) 2001-02-01
BR9912842A (en) 2001-10-16
DE69917282T2 (en) 2005-05-25
HUP0103826A3 (en) 2002-03-28
DE69917282D1 (en) 2004-06-17
CA2339283A1 (en) 2000-02-17
IT1301993B1 (en) 2000-07-20
CA2339283C (en) 2009-03-17
CU23171A3 (en) 2006-09-22
US6515012B2 (en) 2003-02-04
EA200100095A1 (en) 2001-08-27
US20020156293A1 (en) 2002-10-24
ITMI981833A1 (en) 2000-02-04
ATE266635T1 (en) 2004-05-15
HU227557B1 (en) 2011-08-29
EA003454B1 (en) 2003-06-26
HUP0103826A2 (en) 2002-02-28
KR20010072171A (en) 2001-07-31
HK1039616B (en) 2004-10-08
NO20010552L (en) 2001-02-01
US6521760B1 (en) 2003-02-18
BG65022B1 (en) 2006-12-29
SK285527B6 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
BR0308385A (en) (Met) acrylic acid crystals and process for producing and purifying aqueous (met) acrylic acid
BR0112538A (en) Stable salts of o-acetylsalicylic acid with basic amino acids
BR0003117A (en) Processes for the preparation of acrylic acid from propylene, and to purify an aqueous concentrated stream of acrylic acid
PT1102745E (en) PROCESS FOR THE PREPARATION OF CALCIUM SALT OF ZOFENOPRIL
CA2425615A1 (en) Process for the purification of gabapentin using a strong cation exchange resin
FR2844209B1 (en) PROCESS FOR THE NANOFILTRATION PURIFICATION OF A SUGAR-AQUEOUS SOLUTION CONTAINING MONOVALENT AND VERSATILE ANIONS AND CATIONS
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
ES2192000T3 (en) PROCEDURE FOR OBTAINING STERE SALTS FROM ASCORBIL-2-PHOSPHORIC ACID.
KR970001305A (en) Valine Purification Method
DK1113990T3 (en) Process for the preparation of environmentally friendly crystals of sodium chloride
BR9712228A (en) Process for the recovery of lactic acid.
EA200501734A1 (en) METHOD OF OBTAINING (4-HYDROXY-6-OXOTETRAHYDROPYRAN-2-IL) ACETONITRILE AND ITS DERIVATIVES
BRPI0409235A (en) process for the production of 2-hydroxy-4-methylthiobutyric acid ammonium salt
HRP20000749B1 (en) Purification of carboxaldehyde
WO2004087939A8 (en) A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia
BRPI0113939B8 (en) method for the purification of an alpha-hydroxy acid on an industrial scale.
DE50001372D1 (en) Process for the purification of creatine
BR0111412A (en) Processes for recovering an organic acid or metal salt from an alcohol phase
BR0312672A (en) Process for the preparation of compounds
KR960004365A (en) Method for preparing 5'-ribonucleotide calcium
BRPI0409644A (en) process for the preparation of nicotinaldehydes
BRPI0407012A (en) Process for producing a compound and using the compound
RU96122110A (en) METHOD FOR ADAMSIT DESTRUCTION
RO118197B1 (en) Process for obtaining the fixing salt
RU97105137A (en) METHOD FOR PRODUCING TRET-BUTYLAMINE (OPTIONS)